A Dose-Finding Study Comparing InSite Vision, Inc. 101 to Vehicle and DuraSite Alone for Dry Eye Disease

Summary

The purpose of this study is to evaluate the safety, tolerability, and efficacy in topical administration of differing dosing regimens of ISV-101 (Bromfenac in DuraSite® ophthalmic solution) compared to Vehicle and DuraSite alone.

Timeline

Start

2018-01

Primary completion

2018-07

Completion

2019-01

Outcome

Outcome not reported

Stopped: “Project postponed”

Drugs

Indications